What Can and Cannot Be Done Using a Microarray Analysis? Treatment Stratification and Clinical Applications in Oncology (Target Therapy for Cancer : Anti-cancer Drugs Targeting Growth-Factor Signaling Molecules)

スポンサーリンク

概要

• 論文の詳細を見る

著者

• Matsumoto Kazuko

  Department Of Genome Biology Kinki University School Of Medicine

• Maegawa Mari

  Department Of Genome Biology Kinki University School Of Medicine

関連論文

• N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
• Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
• Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
• Plasma concentrations of VCAM-1 and PAI-1 : A predictive biomarker for post-operative recurrence in colorectal cancer
• What Can and Cannot Be Done Using a Microarray Analysis? Treatment Stratification and Clinical Applications in Oncology (Target Therapy for Cancer : Anti-cancer Drugs Targeting Growth-Factor Signaling Molecules)
• What Can and Cannot Be Done Using a Microarray Analysis? Treatment Stratification and Clinical Applications in Oncology

スポンサーリンク